Journal Information
Vol. 46. Issue 1.
Pages 49 (January 2010)
Share
Share
Download PDF
More article options
Vol. 46. Issue 1.
Pages 49 (January 2010)
Letter to the Editor
Full text access
Adalimumab in the Treatment of Parotid Sarcoidosis
Adalimumab en el tratamiento de la sarcoidosis parotídea
Visits
3674
Marta Cufí-Beneta,
Corresponding author
mcufi@hotmail.com

Corresponding author.
, Carles Sabadellb, Oriol Codinac
a Medicina Familiar y Comunitaria, Hospital de Figueres, Figueres, Girona, Spain
b Servicio de Neumología, Hospital de Figueres, Figueres, Girona, Spain
c Servicio de Reumatología, Hospital de Figueres, Figueres, Girona, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
Abbott Laboratories. Highlights of prescribing information. Humira Adalimumab Medication [consultado 30/03/2009]. Available at: http://www.rxabbott.com/pdf/humira.pdf.
[2.]
J.L. Callejas-Rubio, N. Ortego-Centeno, L. López-Pérez, M.N. Benticuaga.
Treatment of therapy-resistant sarcoidosis with adalimumab.
Clin Rheumatol, 25 (2006), pp. 596-597
[3.]
A.U. Wells.
Infliximab in extrapumonary sarcoidosis: tantalising but inconclusive.
Eur Repir J, 31 (2008), pp. 1148-1149
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?